Difficult transmembrane protein targets for therapeutic antibodies

FHS
July 12, 2023
6:48 am

In this interview, News-Medical talks to Sylvia Xie, product scientist at Sino Biological, about the ongoing emergence of transmembrane proteins as targets for therapeutic antibodies.

DocMorris optimises organisational structure and prepares for e-prescription growth in Germany – Biotech Investments

DocMorris AG / Key word(s): Strategic Company Decision 22-Nov-2023 / 07:37 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

November 23, 2023

Heart failure triggers multimorbidity by altering stem cells, study reveals

Researchers identified that heart failure (HF) promotes multimorbidity by altering hematopoietic stem cells (HSCs) to produce pro-inflammatory macrophages, increasing vulnerability in multiple organs. The study

May 28, 2024

Cybin Launches Renewed ATM Equity Program Up To $35M

Psychedelics biotech Cybin Inc. CYBN announced it has renewed its previously established at-the-market (ATM) equity program allowing the company to gradually issue and sell up to $35 million in common shares

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.